CT Perfusion Parameters for Advanced HCC Treated by Systemic Immunotherapy
Condition(s):Advanced HCC Treated by Systemic ImmunotherapyLast Updated:October 17, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Advanced HCC Treated by Systemic ImmunotherapyLast Updated:October 17, 2022Completed
Condition(s):Advanced HCCLast Updated:April 26, 2023Not yet recruiting
Condition(s):Advanced HCC; Other Solid TumorsLast Updated:January 10, 2024Not yet recruiting
Condition(s):Solid TumorsLast Updated:December 8, 2021Not yet recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:September 6, 2017Unknown status
Condition(s):Carcinoma, HepatocellularLast Updated:June 19, 2019Completed
Condition(s):HCCLast Updated:February 29, 2024Not yet recruiting
Condition(s):Advanced Hepatocellular Carcinoma (HCC)Last Updated:September 13, 2023Active, not recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:September 20, 2018Unknown status
Condition(s):Advanced HCCLast Updated:February 4, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.